Table 2.
Progression | ART | Mortality | |
Age-group (years) | |||
15–24 (reference) | 1.0 | 1.0 | |
25–34 | 1.01 (0.94–1.10) | 1.25 (1.13–1.40) | |
35–44 | 0.94 (0.87–1.03) | 1.55 (1.35–1.78) | |
>45 | 0.93 (0.86–1.01) | 2.22 (1.84–2.67) | |
Sex | |||
Male (reference) | 1.0 | 1.0 | |
Female | 0.92 (0.86–0.99) | 1.04 (1.00–1.08) | |
Region | |||
Europe/North America (reference) | 1.0 | 1.0 | 1.0 |
Africa | 0.97 (0.77–1.21) | 0.21 (0.16–0.28) | 2.68 (1.75–4.12) |
SE/E Asia | 1.45 (1.36–1.54) | 0.50 (0.33–0.76) | 1.88 (1.50–2.35) |
ART, antiretroviral therapy; SE/E Asia, Southeast/East Asia.